Copyright
©The Author(s) 2019.
World J Cardiol. Feb 26, 2019; 11(2): 47-56
Published online Feb 26, 2019. doi: 10.4330/wjc.v11.i2.47
Published online Feb 26, 2019. doi: 10.4330/wjc.v11.i2.47
Figure 1 The functional distinction between β-arrestin-1 and β-arrestin-2 in cardiac myocytes.
ATP: Adenosine triphosphate; P: Phosphorylation; SR: Sarcoplasmic reticulum; SUMO1: Small ubiquitin-like modifier protein-1; PLN: Phospholamban; PIP2: Phosphatidyl-inositol 4,5-bisphosphate; IP3: Inositol 1,4,5-trisphosphate; DAG: 1,2-Diacylglycerol; EGFR: Epidermal growth factor receptor; AR: Adrenergic receptor.
- Citation: Lymperopoulos A, Wertz SL, Pollard CM, Desimine VL, Maning J, McCrink KA. Not all arrestins are created equal: Therapeutic implications of the functional diversity of the β-arrestins in the heart. World J Cardiol 2019; 11(2): 47-56
- URL: https://www.wjgnet.com/1949-8462/full/v11/i2/47.htm
- DOI: https://dx.doi.org/10.4330/wjc.v11.i2.47